(NTLA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Get the latest Intellia Therapeutics, Inc. NTLA detailed stock quotes, stock data, Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates. Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary. Prev Close 12.71, 52 Wk Low 9.18. Open 13.03, 52 Wk High 19.00. Day Low 12.00, Volume 446,939.00. Day High 13.09, Avg 10D Vol 555,064.00
Intellia Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. NTLA updated stock price target summary.
Intellia Therapeutics Stock Price Forecast, NTLA stock price prediction. The best long-term & short-term Intellia Therapeutics share price prognosis for 2020, Based on 4 analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $31.83 with a high forecast of NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. Intellia Therapeutics stock price target cut to $16 from $21 at Wedbush. Feb. 14, 2020 Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis.
Stock analysis for Intellia Therapeutics Inc (NTLA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
AC8 Stock Price and Chart — ASX:AC8 — TradingView View live AUSCANN GROUP HOLDINGS LTD chart to track its stock's price action. Find market predictions, AC8 financials and market news. Short to medium term share price forecast. AC8, 30. Rotuma. Share prices recently had a price gap to the upside but seem to be having difficulty breaking out of the price channel and holding above 1.730. Prices. Time and Sales - Intraday Stock Last Price History for ...
Find real-time NVTA - Invitae Corp stock quotes, company profile, news and forecasts from CNN Business.
Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing. Fair Value is the appropriate price Intellia Therapeutics, Inc. - NTLA - Stock Price Today - Zacks View Intellia Therapeutics, Inc. NTLA investment & stock information. Get the latest Intellia Therapeutics, Inc. NTLA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis. Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis.
Online Stock Comparison - Compare Intellia Therapeutics, Inc. (NTLA) to four other stocks with NASDAQ.com's stock comparison tool. NTLA - Intellia Thera CS Stock Price - Barchart.com It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. NTLA - Intellia Thera CS Stock Price History - Barchart.com When negative, the current price is that much lower than the highest price reported for the period. When positive, the current price is that much higher than the highest price from that period. New Lows. This widget shows the number of times this symbol reached a new low price for specific periods, from the past 5-Days to the past 20-Years.
View today's stock price, news and analysis for Intellia Therapeutics Inc. (NTLA). Barron's also provides information on historical stock ratings, target prices, 10 Mar 2020 On Monday, shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) marked ally in the technical patterns of the stock movements showed in stock charts. on the price of NTLA shares, based on the price prediction for NTLA, Current Technical Analysis and interactive chart for $NTLA stock / shares. The stock exhibited some range contraction during this trading session as price made Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates.